The FDA tentatively approved Dr. Reddy’s Laboratories to produce a generic version of the HIV-prevention drug lenacapavir, a step toward expanding access in dozens of low- and middle-income countries; the reported annual cost is $40 per person. Other items in the briefing cover DEA registrations for more than 900 medical marijuana dispensaries, House Democrats seeking answers about U.S. citizens detained by immigration agents, and military-related developments involving Navy working conditions and deployments, veterans’ disability ratings, and restrictions affecting transgender Marines.

The briefing leads with insurers withholding payments to providers after arbitration under the No Surprises Act, amid disputes over high out-of-network awards and uncertainty about enforcing the law. It also covers state efforts to offset rising exchange premiums, FTC warnings about potentially deceptive insurance marketing, and Redeemer Health's Chapter 11 filing. Other developments include a Providence-Compassus home-care venture in Oregon, a completed Florida State University research building, and planned nurse strikes at UI Health and Brigham and Women's Hospital. The roundup also notes a cancer center room honoring Jennifer Schaefer and new national guidance for cancer caregivers.

Abortion rights, health care affordability, and Medicare for All are prominent concerns as voters approach the midterms. Ballot measures in several states could expand or restrict abortion access, while candidates in Michigan and Maine have made Medicare for All a central campaign issue. Polling shows widespread concern about rising health costs, including higher ACA benchmark premiums after enhanced tax credits expired. A large free clinic near Washington, D.C., illustrated the difficulties many people face accessing care. The roundup also notes that the Make America Healthy Again movement has struggled to gain traction on the campaign trail.

Census data show that the uninsured rate among children has generally risen since the pandemic, with a notable increase in Western states and persistently high rates in the South. Experts point to post-pandemic Medicaid eligibility redeterminations as a possible factor and expect policy changes to put further pressure on coverage. The roundup also reports that the overall uninsured rate was little changed in 2025, while household income reached a record high and poverty fell. Other developments include a lawsuit that could affect employer health-plan protections, proposed expansion of a Medicare chronic-disease technology pilot, strong uptake of a Medicare GLP-1 coverage program, and large Medicaid payments to D.C. home-health firms previously flagged in a fraud probe.

The Senate health committee is holding confirmation hearings for President Donald Trump’s nominees to senior Department of Health and Human Services positions, including surgeon general nominee Dr. Nicole Saphier, deputy secretary nominee Chris Klomp, and mental-health nominee Dr. Timothy Westlake. Klomp defended the safety and effectiveness of the measles, mumps and rubella vaccine during questioning, despite skepticism from Trump and Health Secretary Robert F. Kennedy Jr. The briefing also highlights congressional debates over artificial-intelligence regulation and possible Democratic oversight of health-care policy, including Trump’s drug-pricing agreements, if Democrats regain control of Congress.

An 18-year-old unvaccinated Pennsylvania resident has become the state’s fourth measles-associated death in a month, reportedly after developing a rare, severe brain inflammation condition. House Democrats are demanding that the CDC explain why it has not included two Pennsylvania deaths in its weekly national tally. The briefing also reports rising hospitalizations and declining confidence in measles vaccine safety, fewer pediatric visits among immigrant families concerned about immigration enforcement, a Connecticut ruling upholding the removal of religious vaccine exemptions, and continued uncertainty over whether the Ebola outbreak in the Democratic Republic of the Congo has peaked.

Bee biologist Victor Gonzalez and student researchers searched a páramo near Cogua, Colombia, for the high-altitude bumblebee Bombus funebris, which pollinates frailejón plants. Páramos help supply Colombia with water, but climate change and agricultural expansion are shrinking habitat for both the plants and their pollinators; local bee populations have already disappeared from areas around Bogotá. With National Science Foundation support, students from US universities are studying Colombian bees to improve scientific understanding and inform conservation and sustainable agriculture. After hours of searching, the team caught one Bombus funebris specimen.

Millions of people have lost insurance coverage for GLP-1 weight-loss drugs such as Zepbound and Wegovy, prompting patients to navigate exceptions, prior authorizations, and appeals. Some insurers cover the drugs only when tied to conditions like sleep apnea, liver disease, or Type 2 diabetes. Experts advise reviewing policy details, filing appeals with medical documentation, and keeping thorough records, as some plans require step therapy. Patients unable to secure coverage may find discounted prices through drugmakers or online pharmacies, though compounded versions carry safety risks. Alternatives such as Contrave or generic combinations may help until access improves, and long-term expectations suggest GLP-1s may eventually become affordable and widely covered.

Efforts by Florida leaders to roll back childhood vaccine mandates stalled when legislative leaders declined to advance related measures, despite earlier support from Governor Ron DeSantis and Surgeon General Joseph Ladapo. Analysts note that political concerns ahead of elections have made lawmakers cautious, even as public polling shows strong parental support for existing vaccine requirements. A proposed bill adding a personal conscience exemption and restricting mRNA vaccine mandates failed to advance, with some Republicans citing measles outbreaks and public health risks. Regulatory attempts to alter required vaccinations have also paused, leaving mandates unchanged for now amid continued public skepticism and activism around vaccine policy.

Elevance Health paid more than $342 million to the federal government following a CMS enforcement action targeting overbilling in Medicare Advantage plans. The payment, disclosed in court filings, reflects CMS’ threat to block the company from enrolling new members unless billing issues were corrected. Experts view the recovery as a rare and significant step toward stronger oversight of Medicare Advantage overpayments, though the amount represents only a small share of Elevance’s total Medicare revenue. The company is also facing a separate Justice Department False Claims Act case over similar allegations and continues to contest the enforcement action. The development may signal increased federal pressure on insurers but its broader impact on industry practices remains uncertain.